![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 49, 40766-40772, December 9, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Domain Activities Independently Regulate Clathrin Function*
From the Department of Biochemistry and Molecular Biology and the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107
Phosphoinositide 3-kinase C2
(PI3K-C2
) is a member of the class II PI-3 kinases, defined by the presence of a second C2 domain at their C termini. The cellular functions of the class II enzymes are incompletely understood, though they have been implicated in receptor activation pathways initiated by epidermal growth factor, insulin, and chemokines. PI3K-C2
was recently found to be localized to clathrin-coated membranes in the trans-Golgi network and at endocytic sites on the plasma membrane. Further, a specific binding site was identified for clathrin on the N terminus of PI3K-C2
, whose occupancy resulted in lipid kinase activation. Expression of PI3K-C2
in cells dramatically affected clathrin distribution and function in cells, leading to accumulation of intracellular clathrin-coated structures, which are visualized here at the ultrastructural level, and inhibition of clathrin-mediated transport from both the plasma membrane and the trans-Golgi network. In this study we have demonstrated that the isolated clathrin binding domain of PI3K-C2
can drive clathrin lattice assembly and that both it and the lipid kinase activity of the protein can independently modulate clathrin distribution and function when expressed in cells. Together, these results suggest that PI3K-C2
employs both protein-protein interaction and localized production of 3-phosphoinositides to affect clathrin dynamics at sites of membrane budding and targeting.
Received for publication, July 15, 2005 , and in revised form, September 7, 2005.
* This work was supported by National Institutes of Health Grant GM-49217. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Present address: Arena Pharmaceuticals, San Diego, CA 92121.
2 To whom correspondence should be addressed. Tel.: 215-503-4624; E-mail: jim.keen{at}mail.jci.tju.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Falasca, W. E. Hughes, V. Dominguez, G. Sala, F. Fostira, M. Q. Fang, R. Cazzolli, P. R. Shepherd, D. E. James, and T. Maffucci The Role of Phosphoinositide 3-Kinase C2{alpha} in Insulin Signaling J. Biol. Chem., September 21, 2007; 282(38): 28226 - 28236. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, I. Gaidarov, and J. H. Keen Phosphoinositide 3-Kinase C2{alpha} Links Clathrin to Microtubule-dependent Movement J. Biol. Chem., January 12, 2007; 282(2): 1249 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Stahelin, D. Karathanassis, K. S. Bruzik, M. D. Waterfield, J. Bravo, R. L. Williams, and W. Cho Structural and Membrane Binding Analysis of the Phox Homology Domain of Phosphoinositide 3-Kinase-C2{alpha} J. Biol. Chem., December 22, 2006; 281(51): 39396 - 39406. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |